Edward N. Herbert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Edward N. Herbert has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Tom Williamson
Guy's and St. Thomas' NHS Foundation Trust, London, UK
4 shared publications C Groenewald
Royal Liverpool University Hospital, Prescott Street, Liverpool L8 7NP, UK
2 shared publicationsD Wong
Royal Liverpool University Hospital, Prescott Street, Liverpool L8 7NP, UK
2 shared publicationsCarolina Wetterqvist
Department of Ophthalmology, Örebro University Hospital, Örebro, Sweden
1 shared publication- David Hw Steel
Sunderland Eye Infirmary, Queen Alexandra Road, Sunderland, UK
1 shared publication David Wong
St Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool, UK
1 shared publication
Latest Publications
- 1 December 2008
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 36 (9) , 812-816
Nature of subretinal fluid in patients undergoing vitrectomy for macular hole: a cytopathological and optical coherence tomography study
Background: Outer retinal defects (ORDs) may occur after surgical closure of full thickness macular holes (FTMH) and be associated with delayed visual recovery. This may be due to the nature of the subretinal fluid (SRF) cuff and/or the loss of retinal elements.Methods: Vitrectomy with internal limiting membrane (ILM) peel was performed for FTMH. After fluid‐air exchange, SRF was either aspirated from the hole (group 1) or left in situ (group 2). The SRF specimens obtained were examined by light microscopy and correlated with optical coherence tomography (OCT).Results: In group 1, cellular material was found in 6 out of 12 cases. Photoreceptors were seen in 3 and macrophages in 3 cases. Nine of 12 holes closed and ORDs were seen in 3 of these. In group 2, 7 out of 8 holes closed, with 4 having ORD. There was no difference in visual acuity (LogMAR) for closed holes at 3 months between groups 1 (0.61, range 0.3–1) and 2 (0.51, range 0.3–0.78) nor between patients with ORD (0.57, range 0.3–1.0) or without ORD (0.57, range 0.3–1.0).Conclusions: SRF from FTMH may contain macrophages and photoreceptors. Such photoreceptor loss may contribute to reduced retinal function. ORDs occur commonly in spite of fluid aspiration, but their presence is still compatible with good vision. Aspiration of SRF did not appear to confer added benefit in this series.
- 1 December 2008
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 36 (9) , 812-816
Nature of subretinal fluid in patients undergoing vitrectomy for macular hole: a cytopathological and optical coherence tomography study
Background: Outer retinal defects (ORDs) may occur after surgical closure of full thickness macular holes (FTMH) and be associated with delayed visual recovery. This may be due to the nature of the subretinal fluid (SRF) cuff and/or the loss of retinal elements.Methods: Vitrectomy with internal limiting membrane (ILM) peel was performed for FTMH. After fluid‐air exchange, SRF was either aspirated from the hole (group 1) or left in situ (group 2). The SRF specimens obtained were examined by light microscopy and correlated with optical coherence tomography (OCT).Results: In group 1, cellular material was found in 6 out of 12 cases. Photoreceptors were seen in 3 and macrophages in 3 cases. Nine of 12 holes closed and ORDs were seen in 3 of these. In group 2, 7 out of 8 holes closed, with 4 having ORD. There was no difference in visual acuity (LogMAR) for closed holes at 3 months between groups 1 (0.61, range 0.3–1) and 2 (0.51, range 0.3–0.78) nor between patients with ORD (0.57, range 0.3–1.0) or without ORD (0.57, range 0.3–1.0).Conclusions: SRF from FTMH may contain macrophages and photoreceptors. Such photoreceptor loss may contribute to reduced retinal function. ORDs occur commonly in spite of fluid aspiration, but their presence is still compatible with good vision. Aspiration of SRF did not appear to confer added benefit in this series.
- 1 September 2006
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (9) , 1209-1210
Haemorrhagic vitreoretinal complications associated with combined antiplatelet agents
An 83 year old man presented with visual acuity reduced to hand motions in both eyes as a result of dense vitreous haemorrhage. He had hypertension, which was being treated, but was not diabetic. Medications included 75 mg clopidogrel once daily and diclofenac.
- 1 September 2006
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (9) , 1209-1210
Haemorrhagic vitreoretinal complications associated with combined antiplatelet agents
An 83 year old man presented with visual acuity reduced to hand motions in both eyes as a result of dense vitreous haemorrhage. He had hypertension, which was being treated, but was not diabetic. Medications included 75 mg clopidogrel once daily and diclofenac.
- Open Access
- 7 April 2006
- Published by Springer Nature in Eye
- Vol. 21 (7) , 925-929
Combined removal of silicone oil plus internal search (ROSO-plus) following retinal detachment surgery
- 7 April 2006
- Published by Springer Nature in Eye
- Vol. 21 (7) , 925-929
Open AccessCombined removal of silicone oil plus internal search (ROSO-plus) following retinal detachment surgery
- Open Access
- 1 December 2005
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (12) , 1667-1668
Visual loss after silicone oil removal
In their paper, information on acuity for cases 2 and 3, between 1 week after oil insertion and oil removal is not provided. Did these cases have visual loss preceding oil removal? Developing cataract can obviously hinder interpretation of acuity measurements. In our cases the symptoms described did not fit with cataract (scotoma, red desaturation) and persisted if any cataract was removed.
- 1 December 2005
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (12) , 1667-1668
Open AccessVisual loss after silicone oil removal
In their paper, information on acuity for cases 2 and 3, between 1 week after oil insertion and oil removal is not provided. Did these cases have visual loss preceding oil removal? Developing cataract can obviously hinder interpretation of acuity measurements. In our cases the symptoms described did not fit with cataract (scotoma, red desaturation) and persisted if any cataract was removed.
- 27 July 2005
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 244 (2) , 248-252
Central scotoma associated with intraocular silicone oil tamponade develops before oil removal
Background Unexplained sudden visual loss after removal of silicone oil from the eye has recently been described. We report the occurrence and features of unexplained central scotoma developing with silicone oil in situ in the vitreous cavity. Methods A retrospective case series of five patients (from two centres) who reported a central scotoma commencing during silicone oil tamponade was studied. All patients had vitrectomy for macula-on retinal detachment, with ultra-purified silicone oil tamponade (four out of five had giant retinal tear). Investigations included visual acuity, intraocular pressure, optical coherence tomography, fluorescein angiography, visual fields and electrophysiology. Results All patients reported a central scotoma that appeared during oil tamponade. Visual acuity fell by a mean of 0.93 LogMAR units after onset of the scotoma. After cataract extraction and oil removal, vision remained reduced by a mean of 0.8 units. The mean duration of oil in the eye was 2.7 months when the scotoma was noted by the patient. Investigations were performed after removal of oil. Fluorescein angiography (FFA) was performed in two cases and optical coherence tomography (OCT) in five patients. No abnormality was demonstrated. Electrophysiology was performed in five patients with pattern electroretinography suggestive of macular dysfunction in four patients. Conclusion This is the first case series describing central scotoma associated with silicone oil in situ. Electrophysiology indicated macular dysfunction in most cases. We suggest that early removal of oil in cases with good visual potential should be considered to avoid this sight-threatening complication.
- 27 July 2005
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 244 (2) , 248-252
Central scotoma associated with intraocular silicone oil tamponade develops before oil removal
Background Unexplained sudden visual loss after removal of silicone oil from the eye has recently been described. We report the occurrence and features of unexplained central scotoma developing with silicone oil in situ in the vitreous cavity. Methods A retrospective case series of five patients (from two centres) who reported a central scotoma commencing during silicone oil tamponade was studied. All patients had vitrectomy for macula-on retinal detachment, with ultra-purified silicone oil tamponade (four out of five had giant retinal tear). Investigations included visual acuity, intraocular pressure, optical coherence tomography, fluorescein angiography, visual fields and electrophysiology. Results All patients reported a central scotoma that appeared during oil tamponade. Visual acuity fell by a mean of 0.93 LogMAR units after onset of the scotoma. After cataract extraction and oil removal, vision remained reduced by a mean of 0.8 units. The mean duration of oil in the eye was 2.7 months when the scotoma was noted by the patient. Investigations were performed after removal of oil. Fluorescein angiography (FFA) was performed in two cases and optical coherence tomography (OCT) in five patients. No abnormality was demonstrated. Electrophysiology was performed in five patients with pattern electroretinography suggestive of macular dysfunction in four patients. Conclusion This is the first case series describing central scotoma associated with silicone oil in situ. Electrophysiology indicated macular dysfunction in most cases. We suggest that early removal of oil in cases with good visual potential should be considered to avoid this sight-threatening complication.
- 19 April 2005
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 243 (10) , 1069-1070
Severe ocular involvement in disseminated intravascular coagulation complicating meningococcaemia
Disseminated intravascular coagulation (DIC) is characterized by inappropriate widespread activation of coagulation leading to extensive microvascular thrombosis and haemorrhage. Ocular involvement typically manifests as fibrin–platelet clots in the choroidal vessels of the posterior pole with overlying serous retinal detachment and sparing of the retinal vessels.
- 19 April 2005
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 243 (10) , 1069-1070
Severe ocular involvement in disseminated intravascular coagulation complicating meningococcaemia
Disseminated intravascular coagulation (DIC) is characterized by inappropriate widespread activation of coagulation leading to extensive microvascular thrombosis and haemorrhage. Ocular involvement typically manifests as fibrin–platelet clots in the choroidal vessels of the posterior pole with overlying serous retinal detachment and sparing of the retinal vessels.
- 18 December 2003
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 242 (3) , 250-254
Tamponade properties of double-filling with perfluorohexyloctane and silicone oil in a model eye chamber
Background The use of perfluorohexyloctane as a heavier-than-water tamponade for long-term use is limited by its tendency to dispersion and associated intraocular inflammation. Double-filling with silicone oil and F6H8 produces a united, two-layer bubble, appearing as a single bubble. This has been proposed as a method of improving the utility of F6H8 as a tamponade. Methods A surface modified polymethylmethacrylate model eye chamber was double-filled with perfluorohexyloctane and silicone oil to approximate a 90% fill. The proportion of silicone oil was increased in a stepwise fashion. A qualitative comparison of surface contact at each stage was made. Chambers with one, two or no indent were used. Dispersion by agitation of the chamber was assessed. Results With less than 20% silicone oil it was difficult to force the two liquids to make contact. With more oil they united in the form of a single bubble joined at an interface. Once joined, the sides of the single bubble were drawn away from the wall of the chamber. As the proportion of silicone oil increased the area of lost contact increased and progressed inferiorly. Compared to F6H8 alone the double-fill reduced dispersion. Conclusion Silicone oil and F6H8 can unite to form a single bubble that changes the effectiveness of either tamponade agent on their own. The double-fill needs to have enough silicone oil to form a single bubble, but this needs to be kept as low as possible to avoid progressive loss of lateral tamponade. It does not provide good simultaneous superior and inferior tamponade. The double-fill reduces dispersion.
- 18 December 2003
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 242 (3) , 250-254
Tamponade properties of double-filling with perfluorohexyloctane and silicone oil in a model eye chamber
Background The use of perfluorohexyloctane as a heavier-than-water tamponade for long-term use is limited by its tendency to dispersion and associated intraocular inflammation. Double-filling with silicone oil and F6H8 produces a united, two-layer bubble, appearing as a single bubble. This has been proposed as a method of improving the utility of F6H8 as a tamponade. Methods A surface modified polymethylmethacrylate model eye chamber was double-filled with perfluorohexyloctane and silicone oil to approximate a 90% fill. The proportion of silicone oil was increased in a stepwise fashion. A qualitative comparison of surface contact at each stage was made. Chambers with one, two or no indent were used. Dispersion by agitation of the chamber was assessed. Results With less than 20% silicone oil it was difficult to force the two liquids to make contact. With more oil they united in the form of a single bubble joined at an interface. Once joined, the sides of the single bubble were drawn away from the wall of the chamber. As the proportion of silicone oil increased the area of lost contact increased and progressed inferiorly. Compared to F6H8 alone the double-fill reduced dispersion. Conclusion Silicone oil and F6H8 can unite to form a single bubble that changes the effectiveness of either tamponade agent on their own. The double-fill needs to have enough silicone oil to form a single bubble, but this needs to be kept as low as possible to avoid progressive loss of lateral tamponade. It does not provide good simultaneous superior and inferior tamponade. The double-fill reduces dispersion.
- Open Access
- 1 July 2003
- Published by BMJ in British Journal of Ophthalmology
- Vol. 87 (7) , 921-922
Treatment of retinal folds using a modified macula relocation technique with perfluoro-hexyloctane tamponade
A 51 year old man with Terson’s syndrome was found to have retinal detachment on B-scan ultrasonography. He underwent vitrectomy and lensectomy with C2F6 gas tamponade for a superior, macula off retinal detachment. He was postured face down overnight. A retinal fold crossing the macula was noted on the first postoperative day (Fig 1A). At 3 months the best corrected acuity was 6/24. The patient described the image in the affected eye as being split diagonally, with the two half images separated. He was referred to our unit for further management.
- 1 July 2003
- Published by BMJ in British Journal of Ophthalmology
- Vol. 87 (7) , 921-922
Open AccessTreatment of retinal folds using a modified macula relocation technique with perfluoro-hexyloctane tamponade
A 51 year old man with Terson’s syndrome was found to have retinal detachment on B-scan ultrasonography. He underwent vitrectomy and lensectomy with C2F6 gas tamponade for a superior, macula off retinal detachment. He was postured face down overnight. A retinal fold crossing the macula was noted on the first postoperative day (Fig 1A). At 3 months the best corrected acuity was 6/24. The patient described the image in the affected eye as being split diagonally, with the two half images separated. He was referred to our unit for further management.
- Open Access
- 1 April 2002
- Published by BMJ in British Journal of Ophthalmology
- Vol. 86 (4) , 387-389
Vitreous penetration of levofloxacin in the uninflamed phakic human eye
Aims: To assess the vitreous penetration of oral levofloxacin (a new fluoroquinolone antibiotic with improved Gram positive activity) in uninflamed phakic eyes. Methods: 15 patients for macula hole surgery were recruited to the study. 10 received a single 500 mg dose of levofloxacin by mouth preoperatively. Five acted as controls. Serum and undiluted vitreous samples were obtained at surgery and analysed by HPLC. Results: Levofloxacin was detectable 2.5 hours after administration in the vitreous. A peak concentration of 1.6 μg/ml (or mg/l) was measured between 2.5 and 4 hours post-dose. Conclusion: Oral levofloxacin reaches the vitreous rapidly in the uninflamed phakic eye. Levels did not reach MIC90 for the commonest infecting organisms. Nevertheless, levofloxacin would be expected to be active against a higher proportion of infecting organisms than either ciprofloxacin or ofloxacin.
- 1 April 2002
- Published by BMJ in British Journal of Ophthalmology
- Vol. 86 (4) , 387-389
Open AccessVitreous penetration of levofloxacin in the uninflamed phakic human eye
Aims: To assess the vitreous penetration of oral levofloxacin (a new fluoroquinolone antibiotic with improved Gram positive activity) in uninflamed phakic eyes. Methods: 15 patients for macula hole surgery were recruited to the study. 10 received a single 500 mg dose of levofloxacin by mouth preoperatively. Five acted as controls. Serum and undiluted vitreous samples were obtained at surgery and analysed by HPLC. Results: Levofloxacin was detectable 2.5 hours after administration in the vitreous. A peak concentration of 1.6 μg/ml (or mg/l) was measured between 2.5 and 4 hours post-dose. Conclusion: Oral levofloxacin reaches the vitreous rapidly in the uninflamed phakic eye. Levels did not reach MIC90 for the commonest infecting organisms. Nevertheless, levofloxacin would be expected to be active against a higher proportion of infecting organisms than either ciprofloxacin or ofloxacin.